Search Orphan Drug Designations and Approvals
-
| Generic Name: | Cytomegalovirus DNA vaccine with plasmids expressing pp65 and gB genes |
|---|---|
| Date Designated: | 06/03/2005 |
| Orphan Designation: | Prevention of clinically significant cytomegalovirus (CMV) viremia, CMV disease and associated complications in at-risk hematopoietic cell transplant and solid transplant populations |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Astellas Pharma Global Development, Inc. 1 Astellas Way Northbrook, Illinois 60062 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







